| Literature DB >> 29935988 |
Xuanyi Ma1, Justin Liu2, Wei Zhu3, Min Tang3, Natalie Lawrence3, Claire Yu3, Maling Gou4, Shaochen Chen5.
Abstract
3D bioprinting is emerging as a promising technology for fabricating complex tissue constructs with tailored biological components and mechanical properties. Recent advances have enabled scientists to precisely position materials and cells to build functional tissue models for in vitro drug screening and disease modeling. This review presents state-of-the-art 3D bioprinting techniques and discusses the choice of cell source and biomaterials for building functional tissue models that can be used for personalized drug screening and disease modeling. In particular, we focus on 3D-bioprinted liver models, cardiac tissues, vascularized constructs, and cancer models for their promising applications in medical research, drug discovery, toxicology, and other pre-clinical studies.Entities:
Keywords: 3D printing; Biomaterials; Disease model; Drug screening; In vitro culture; Tissue engineering; Tissue model
Mesh:
Year: 2018 PMID: 29935988 PMCID: PMC6226327 DOI: 10.1016/j.addr.2018.06.011
Source DB: PubMed Journal: Adv Drug Deliv Rev ISSN: 0169-409X Impact factor: 15.470